Assessment of Lipid Profile and Follistatin in Osteoarthritis
Keywords:
Lipid, follistatin, osteoarthritisAbstract
Osteoarthritis (OA) is a degenerative joint disease and a significant cause of disability worldwide. This study aimed to evaluate lipid profile abnormalities and serum follistatin levels in OA patients compared to healthy controls, elucidating their roles in disease pathogenesis. A case-control design included 50 OA patients and 50 age- and sex-matched controls. Lipid parameters, including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), were analyzed alongside serum follistatin levels measured by enzyme-linked immunosorbent assay (ELISA). OA patients exhibited significantly higher TC, TG, and LDL-C levels and lower HDL-C levels than controls. Serum follistatin levels were also significantly elevated in OA patients and showed positive correlations with TC, TG, and LDL-C and a negative correlation with HDL-C. These findings highlight the interplay between lipid metabolism and inflammatory mediators in OA and suggest that lipid profile and follistatin levels may serve as potential biomarkers or therapeutic targets for the disease.
References
Blasioli, D. J., & Kaplan, D. L. (2014). The roles of catabolic factors in the development of osteoarthritis: nitric oxide, matrix metalloproteinases, and pro-inflammatory cytokines. Arthritis Research & Therapy, 16(5), 441. https://doi.org/10.1186/s13075-014-0441-7
Saito, T., & Tanaka, S. (2017). Molecular mechanisms underlying osteoarthritis development: Notch and NF-κB. Arthritis Research & Therapy, 19(1), 94. https://doi.org/10.1186/s13075-017-1306-x
Felson, D. T. (2006). Osteoarthritis of the knee. The New England Journal of Medicine, 354(8), 841-848. https://doi.org/10.1056/NEJMcp051726
Bijlsma, J. W., Berenbaum, F., & Lafeber, F. P. (2011). Osteoarthritis: an update with relevance for clinical practice. The Lancet, 377(9783), 2115-2126. https://doi.org/10.1016/S0140-6736(11)60243-2
Mobasheri, A., & Batt, M. (2016). An update on the pathophysiology of osteoarthritis. Annals of Physical and Rehabilitation Medicine, 59(5-6), 333-339. https://doi.org/10.1016/j.rehab.2016.07.004
Hunter, D. J., & Bierma-Zeinstra, S. (2019). Osteoarthritis. The Lancet, 393(10182), 1745-1759. https://doi.org/10.1016/S0140-6736(19)30417-9
Glyn-Jones, S., Palmer, A. J., Agricola, R., Price, A. J., Vincent, T. L., Weinans, H., & Carr, A. J. (2015). Osteoarthritis. The Lancet, 386(9991), 376-387. https://doi.org/10.1016/S0140-6736(14)60802-3
Silverwood, V., Blagojevic-Bucknall, M., Jinks, C., Jordan, J. L., Protheroe, J., & Jordan, K. P. (2015). Current evidence on risk factors for knee osteoarthritis in older adults: A systematic review and meta-analysis. Osteoarthritis and Cartilage, 23(4), 507-515. https://doi.org/10.1016/j.joca.2014.11.019
Robinson, W. H., Lepus, C. M., Wang, Q., Raghu, H., Mao, R., Lindstrom, T. M., & Sokolove, J. (2016). Low-grade inflammation is a key mediator of the pathogenesis of osteoarthritis. Nature Reviews Rheumatology, 12(10), 580-592. https://doi.org/10.1038/nrrheum.2016.136
Heinegård, D., & Saxne, T. (2011). The role of the cartilage matrix in osteoarthritis. Nature Reviews Rheumatology, 7(1), 50-56. https://doi.org/10.1038/nrrheum.2010.198
Bultink, I. E., & Lems, W. F. (2013). Osteoarthritis and osteoporosis: what is the overlap? Current Rheumatology Reports, 15(5), 328. https://doi.org/10.1007/s11926-013-0328-0
Chen, D., Shen, J., Zhao, W., Wang, T., Han, L., Hamilton, J. L., & Im, H. J. (2017). Osteoarthritis: toward a comprehensive understanding of the pathological mechanism. Bone Research, 5, 16044. https://doi.org/10.1038/boneres.2016.44
Neogi, T. (2013). The epidemiology and impact of pain in osteoarthritis. Osteoarthritis and Cartilage, 21(9), 1145-1153. https://doi.org/10.1016/j.joca.2013.03.018
Thomas, C. M., & Fuller, C. J. (2018). Oxidized low-density lipoprotein and inflammation in osteoarthritis. Current Opinion in Rheumatology, 30(1), 76-82. https://doi.org/10.1097/BOR.0000000000000453
Sellam, J., & Berenbaum, F. (2010). The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nature Reviews Rheumatology, 6(11), 625-635. https://doi.org/10.1038/nrrheum.2010.159
Blasioli, D. J., & Kaplan, D. L. (2014). The roles of catabolic factors in the development of osteoarthritis: nitric oxide, matrix metalloproteinases, and pro-inflammatory cytokines. Arthritis Research & Therapy, 16(5), 441. https://doi.org/10.1186/s13075-014-0441-7
Courties, A., Sellam, J., Maheu, E., & Cadet, C. (2017). Osteoarthritis and type 2 diabetes mellitus: What are the links? Diabetes Research and Clinical Practice, 130, 59-68. https://doi.org/10.1016/j.diabres.2017.05.001
Loeser, R. F., Goldring, S. R., Scanzello, C. R., & Goldring, M. B. (2012). Osteoarthritis is a disease of the joint as an organ. Arthritis and Rheumatism, 64(6), 1697-1707. https://doi.org/10.1002/art.34453
Conaghan, P. G., Vanharanta, H., & Dieppe, P. A. (2005). Is progressive osteoarthritis an atheromatous vascular disease? Annals of the Rheumatic Diseases, 64(11), 1539-1541. https://doi.org/10.1136/ard.2005.036723
Berenbaum, F. (2013). Osteoarthritis is an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis and Cartilage, 21(1), 16-21. https://doi.org/10.1016/j.joca.2012.11.012
Greene, M. A., & Loeser, R. F. (2015). Aging-related inflammation in osteoarthritis. Osteoarthritis and Cartilage, 23(11), 1966-1971. https://doi.org/10.1016/j.joca.2015.01.008
Goldring, M. B., & Goldring, S. R. (2007). Osteoarthritis. Journal of Cellular Physiology, 213(3), 626-634. https://doi.org/10.1002/jcp.21258
Ding, C., Parameswaran, V., Udayan, R., Burgess, J., & Jones, G. (2008). Circulating levels of inflammatory markers predict change in knee pain over 5 years in older adults: a prospective cohort study. Annals of the Rheumatic Diseases, 67(11), 1725-1730. https://doi.org/10.1136/ard.2007.080107
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J. P., & Fahmi, H. (2011). Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nature Reviews Rheumatology, 7(1), 33-42. https://doi.org/10.1038/nrrheum.2010.196
de Munter, W., van der Kraan, P. M., & van den Berg, W. B. (2013). Inflammatory pathways in cartilage damage and repair. Clinical and Experimental Rheumatology, 31(5 Suppl 78), S63-S67.
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., ... & Murray, C. J. (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1545-1602. https://doi.org/10.1016/S0140-6736(16)31678-6
